Sign in
Interim Results of the Dropless Pars Plana Vitrectomy Study
Nimesh A. Patel, MD
Updates from the Field
2024
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
2017
Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
2019
Category: Ocular Oncology